Register for OBR daily


IMS_White_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

AEZS $1.50 0.1000 +7.14%
AMBI $7.57 0.4700 +6.62%
ARGS $9.39 0.5700 +6.46%
ECYT $7.36 0.3799 +5.44%
ENZN $1.64 0.0800 +5.13%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

OMED $20.29 -1.2900 -5.98%
SNSS $7.49 -0.2900 -3.73%
DRNA $13.78 -0.4500 -3.16%
CNDO $2.10 -0.0600 -2.78%
XLRN $26.87 -0.5800 -2.11%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Not Enough Data on Anemia Drugs, Transplants: Panel

(Reuters) Jan 19, 2011 - There is not enough data to prove widely used anemia drugs made by Amgen Inc and Johnson & Johnson improve outcomes for kidney patients who undergo organ transplantation, a U.S. Medicare advisory panel said on Wednesday.
read article 



Health Journals May Force Reporting of Hedge Fund Ties

(Bloomberg) Jan 19, 2011 - The New England Journal of Medicine and 13 other research publications may force scientists who submit studies to disclose payments from hedge funds in the wake of insider-trading probes involving a drugmaker and technology companies.
read article 



MannKind Says FDA Wants Two New Clinical Trials of Its Insulin Inhaler

(Los Angeles Times) Jan 19, 2011 - MannKind Corp. divulged that the Food and Drug Administration has asked for more testing of its key, long-delayed product — an insulin inhaler for people with diabetes.
read article (free registration required) 



Merck Details Setback on Anticlotting Drug

(Wall Street Journal) Jan 20, 2011 - Merck & Co. said concerns about an increased risk of hemorrhagic stroke--or bleeding in the brain--in patients with a history of stroke led to last week's decision to halt one major study of its experimental heart drug vorapaxar and curb participation in another.
read article (paid subscription required) 



Genentech Says Melanoma Drug Met Study Goal

(AP/Bloomberg) Jan 19, 2011 - The drugmaker Genentech said its cancer drug RG7204 improved survival for people with melanoma, and slowed the progress of the disease.
read article 



Roche Pipeline Gets Lift After Strong RG7204 Skin Cancer Data

(Dow Jones Newswires/FOX Business) Jan 19, 2011 - Swiss drug giant Roche Holding AG Wednesday said its promising new skin cancer drug helps patients with advanced forms of the disease live longer and without their illness getting worse, according to late-stage trial data.
read article 



Genentech Appeals Avastin Decision

(NYT Prescriptions Blog) Jan 18, 2011 - Genentech on Tuesday formally asked the Food and Drug Administration to overturn last month’s decision revoking the approval of the drug Avastin as a treatment for breast cancer.
read article (free registration required) 



Merck KGaA: Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With FOLFOX

(Merck KGaA) Jan 19, 2011 – Merck KGaA today highlighted a further analysis of the large randomized Phase II OPUSa study demonstrating an association between early tumor shrinkage and long-term median overall survival (OS) of more than 2 years for patients with KRAS wild-type metastatic colorectal cancer (mCRC) treated with Erbitux® (cetuximab) plus FOLFOX standard chemotherapy.
download pdf 



New Advances Aimed at Improving Treatment of Gastrointestinal Cancers

(ASCO) Jan 18, 2011 - New research into the treatment of gastrointestinal cancers – and novel ways to predict recurrence and response to chemotherapy – was released today in advance of the eighth annual Gastrointestinal Cancers Symposium, which will be held January 20-22, 2011, at The Moscone West Building in San Francisco, Ca.
read press release 



Pfizer in Deal With Theraclone for Antibody Drug Research

(New York Times) Jan 18, 2011 - Pfizer, the world’s largest drug company, has agreed to pay up to $632 million to Theraclone Sciences in a research collaboration on antibody drugs for cancer and infectious disease, the companies said Tuesday.
read article (free registration required) 



Gene Test Might Predict Colon Cancer's Return

(Bloomberg Businessweek) Jan 19, 2011 - A genetic test seems able to identify which people with stage II colon cancer face a higher risk of recurrence, German researchers report.
read article 



ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine(TM) NDA

(ADVENTRX) Jan 19, 2011 - ADVENTRX Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011 for the review of the Exelbine (ANX-530) New Drug Application (NDA).
read press release 



'Patchwork' of Gene Faults Could Help Predict Cervical Cancer Drug Success

(Cancer Research UK) Jan 19, 2011 - Cancer Research UK scientists have discovered that cervical cancer patients who have a mixture of different genetic faults in their tumour at the start of treatment may be more likely to relapse, according to a study published in the British Journal of Cancer today.
read press release 



Amgen Sells Bay Area Facility

(Ventura County Star) Jan 18, 2011 - Amgen Inc. announced today that it plans to sell its manufacturing and development facility in Fremont to a private contract company.
read article 



Diabetics Diagnosed With Breast Cancer 50 Percent More Likely to Die

(FOX News) Jan 18, 2011 - Women who have been diagnosed with breast cancer are nearly 50 percent more likely to die from any cause if they have diabetes, according to a study from Johns Hopkins University School of Medicine.
read article 



Keep Your Voice, Even at the End of Life

(NYT Personal Health Column) Jan 17, 2011 - The specter of “death panels” was raised yet again this month, prompting the Obama administration to give in to political pressure a second time in its effort to encourage end-of-life planning.
read article (free registration required) 



Damage of 'False-Positive' Mammograms Overlooked: Study

(U.S. News & World Report) Jan 18, 2011 - Women should be made aware of the potential downsides of breast cancer screenings, a team of Dutch doctors urges, because false-positive results can prompt anxiety and seriously undermine a patient's quality of life.
read article 



Men Who Smoke Might Shorten Their Lives, a New European Study Says

(LAT Booster Shots Blot) Jan 18, 2011 - Hey, guys, here's another reason to stop smoking -- it might increase your chances of living as long as a wife, girlfriend, sister or gal pal. Deaths linked to smoking have been identified as the key reason why European women outlive men.
read article (free registration required) 



Researchers Discover How Progesterone May Increase Breast Cancer Risk

(MSU) Jan 18, 2011 - Researchers have identified how the hormones progesterone and estrogen interact to increase cell growth in normal mammary cells and mammary cancers, a novel finding that may explain why postmenopausal women receiving hormone replacement therapy with estrogen plus progestin are at increased risk of breast cancer.
read press release 



M.D. Anderson Receives $150 Million Gift

(Houston Chronicle) Jan 18, 2011 - The University of Texas M.D. Anderson Cancer Center is receiving $150 million from the president of the United Arab Emirates, the largest donation ever given to an institution in the Texas Medical Center.
read article 



Is Soy Linked to Breast Cancer?

(CNN Health Blog) Jan 19, 2011 - One of my neighbors has breast cancer. Her doctor has asked her to completely stop eating soy and its products, including edamame and tofu.
read article 



CareCore National and UPMC Affiliate Join Forces to Offer Proven Strategy for Improving Quality and Value of Cancer Care

(Yahoo! Finance) Jan 18, 2011 - To improve quality and contain rising costs in cancer care, CareCore National and D3, an affiliate of UPMC, have formed a new company to accelerate implementation of cancer care pathways.
read article 



HIV-Positive Head and Neck Cancer Patients Benefit From Radiation Therapy

(ASTRO) Jan 18, 2011 - HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience similar toxicity rates as non-HIV-positive patients, despite prior reports to the contrary, according to a study in the January issue of the International Journal of Radiation Oncology•Biology•Physics.
read press release 



Director of Oncology Basic Research at the John Theurer Cancer Center Continues Research Aimed at Improving Allogeneic Blood and Marrow Transplantation

(John Theurer) Jan 18, 2011 - Thea Friedman, M.D., associate scientist and director of oncology basic research at the John Theurer Cancer Center at Hackensack University Medical Center was recently awarded a National Institutes of Health-National Cancer Institute (NIH-NCI) RO1 research grant to improve allogeneic blood and marrow transplantation for multiple myeloma patients.
read press release 



Molecular Battle in Cancer Cells Offers Clues for Treatment

(UNC Lineberger) Jan 19, 2011 - Researchers investigating a genetic mutation in brain cancer and leukemia patients have discovered how one cancer metabolite battles another normal metabolite to contribute cancer development. Helping the “good guys” win that battle could yield new approaches for treatment.
read press release